MARKET

LGND

LGND

Ligand Pharma
NASDAQ
121.70
-3.28
-2.62%
After Hours: 118.55 -3.15 -2.59% 19:06 07/11 EDT
OPEN
124.52
PREV CLOSE
124.98
HIGH
124.52
LOW
120.74
VOLUME
106.49K
TURNOVER
--
52 WEEK HIGH
129.90
52 WEEK LOW
85.18
MARKET CAP
2.35B
P/E (TTM)
-17.0949
1D
5D
1M
3M
1Y
5Y
1D
Director John W. Kozarich Reports Disposal of Common Shares in Ligand Pharmaceuticals Inc
Reuters · 2d ago
Ligand Pharma (LGND) Gets a Buy from Craig-Hallum
TipRanks · 2d ago
Pelthos Therapeutics Launches First At-Home Prescription Gel For Highly Contagious Skin Disease
Benzinga · 3d ago
Ligand Pharm's Partner Pelthos Therapeutics Commercially Launches ZELSUVMI Topical Gel 10.3%, FDA-Approved At-Home Treatment For Molluscum Contagiosum
Benzinga · 3d ago
LIGAND PHARMACEUTICALS INC - EARNS $5 MLN MILESTONE PAYMENT FROM PELTHOS FOLLOWING COMMERCIAL LAUNCH OF ZELSUVMI
Reuters · 3d ago
LIGAND PARTNER PELTHOS THERAPEUTICS LAUNCHES ZELSUVMI™
Reuters · 3d ago
Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday
Benzinga · 4d ago
Reported July 3, 2025: Pelthos Therapeutics 13D Filing Shows Ligand Pharmaceuticals Discloses 49.9% Stake As Of July 1, 2025
Benzinga · 6d ago
More
About LGND
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. It does this by financing, licensing its technologies or both. It operates two infrastructure-light royalty-generating IP platform technologies. Its Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. This technology has enabled FDA-approved products, including Gilead’s Veklury, Amgen’s Kyprolis, Baxter’s Nexterone, and Acrotech Biopharma’s Evomela. Its NITRICIL platform technology facilitates tunable dosing, permitting an adjustable drug release profile to allow proprietary formulations that target a range of indications. Its technologies also include HepDirect, LTP and BEPro Technology Platform, and Pelican Expression Technology. It has multiple alliances, licenses and other business relationships with various pharmaceutical companies.

Webull offers Ligand Pharmaceuticals Inc stock information, including NASDAQ: LGND real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LGND stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LGND stock methods without spending real money on the virtual paper trading platform.